PEStore

Growth Equity

Quadrant Private Equity

Quadrant Private Equity takes minority stakes in growing companies, usually without full control, from Sydney, Australia. It states a focus on healthcare & life sciences, media & communications and consumer & retail.

Disclosed holdings37
Earliest stated investment2025
HeadquartersSydney, Australia
Stated fund size$200m+

Stated investment criteria

What Quadrant Private Equity says it buys

Read from Quadrant Private Equity’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Transaction typesBuy-and-build1

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Nothing here is a commitment by Quadrant Private Equity to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Quadrant Private Equity is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised10 · $4.0bn gross
SEC adviser numberCRD 163090

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Quadrant Private Equity lists on its own website. 2 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Carlisle Health20251
Stanley College20260
AS Colour
Advancednavigation
Affinityeducation
Aidacare
Amartfurniture
Apm
Bastionsecurity
Birchandwaite
Cancercare
Circuitwise
Connetico
Emmconsulting
Endgameanalytics
Evolutionsurgical
Fitlg
Fitz
Htw
Jaybro
Junioradventuresgroup
Legalvision
Lovetodream
Motorone
Mymusclechef
Nectar
Nzhealthgroup
Papinelle
Partneredhealth
QMS
Ritebitegroup
Seertechsolutions
Southernstarresearch
Tdgenvironmental
Teeg
Tgisport
Tsariley

Compiled from Quadrant Private Equity’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Recorded transactions

Buying and selling

Deals in which Quadrant Private Equity is named as buyer or seller in the transaction archive. 3 recorded exits, most recently in 2021. 4 recorded acquisitions.

CompanySideCounterpartyYearConsideration
iSentiaSoldAccess Intelligence2021$67m
Arq Group - Arq EnterpriseBoughtWebcentral2020$35m
APN Outdoor Group Ltd.SoldJCDecaux SA2018$796m
Real Pet FoodSoldNew Hope Group2018$770m
Darrell LeaBought2018$200m
Jetts FitnessBought2016$71m
Real Pet FoodBought2015$314m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Quadrant Private Equity?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other growth equity investors active in healthcare & life sciences.